Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis

The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.

Inclusion Criteria:

• cirrhosis diagnosis,
• 6 months or more after since most recent imaging.

Exclusion Criteria:

• previous liver transplant,
• HCC diagnosis,
• receiving hospice care,
• completed external imaging in the past 6 months.